Recent Posts
- Breakthrough Cited for Recurrent Glioblastoma (CME/CE)
- Boosting Boron’s Expanding Use In Medicine
- Lipid Involved With Gene Regulation Uncovered
- Unlicensed Intravenous Form Of Relenza Helped Save Life Of Swine-Flu Infected Woman Who Had Just Had Chemotherapy
- Anticancer Compound Found In American Mayapple
Random Posts
- ASCO: Small Survival Nudge for Preop Chemo in Non-Small Cell Lung Cancer (CME/CE)
- Dexamethasone-Based Therapy Shows Improvement In Survival For Children With Acute Lymphoblastic Leukaemia
- Narrow-Band Imaging Shows Better Specificity (CME/CE)
- Green Tea: Mixed Reviews For Cancer Prevention
- Novel Mechanism Controlling Tumor Growth In The Brain Revealed By Scripps Research Scientists
- Cell Growth Abnormalities Predisposing People To Cancer Show Up In Cultured Skin Cells
- Technique Eradicates Problems In Most Patients With Barrett's Esophagus
- Novel Cell Therapies To Treat Cancer
- Florida Clinicians Now Delivering Non-Invasive Image-Guided Treatments Using Novalis Tx(TM) Radiosurgery Technology
- News From The Journal Of Clinical Investigation, May 1, 2009
Prescription Cancer Drugs
Yale Researchers Find Tools Needed To Build A Cellular Shredder
Posted by: admin in Prescription Cancer Drugs on September 06th, 2009
Yale University researchers have discovered a set of cellular chaperones needed to assemble a proteasome, the cellular workhorse that recycles proteins and is crucial for the existence of all eukaryotic cells.
Even though proteasomes are a target of new generation of cancer drugs and their malfunction contributes to neurodegenerative diseases such as Alzheimer’s disease, little is known about how this complex machine assembles itself within cells.
Working with yeast, a team led by Mark Hochstrasser, Eugene Higgins Professor of Molecular Biophysics & Biochemistry, discovered four factors called assembly chaperones that are crucial to the construction of a key part of the proteasome complex. Their findings are reported in Friday’s edition of the journal Cell.
“Our discovery of these factors and their initial characterization is just the first step toward understanding how they operate,” Hochstrasser said. “A lot of different proteins have to come together to makes a full proteasome.”
Proteasomes are a sort of cellular shredder, taking specific proteins within the cell and breaking them apart so they will not block cell proliferation or accumulate to toxic levels. A single mammalian cell might have as many as 800,000 proteasomes.
Sometimes, however, proteasomes can shred proteins that would otherwise cause cancer cells to die. A drug that inhibits proteasomes has been approved as a therapy against cancer. Conversely, malfunctions of the proteasome can lead to aggregation of harmful proteins such as those associated with Alzheimer’s disease. Understanding how proteasomes are constructed will help researchers identify mechanisms to intervene in these diseases processes, Hochstrasser said.
Other Yale researchers who contributed to the paper are Minoru Funakoshi and Robert J. Tomko Jr.
The study was funded by grants from the National Institutes of Health.
Citation:
Cell: May 29, 2009
Source
Yale University
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.